Regulation of human natural killer (NK) cell function: induction of killing of an NK-resistant renal carcinoma cell line.
Natural killer (NK)-like activity against a renal carcinoma cell line, Cur, was assessed. There was no spontaneous killing of Cur cells by human peripheral blood mononuclear cells in 4-hr assays. Cur killing was observed in 18-hr assays, but the magnitude of killing was variable and always markedly less than that against K562. Cur killing was mediated by a nonadherent, nonphagocytic lymphocyte, the activity of which could be modulated both positively and negatively by monocytes or their products. Preincubation of effectors with monocyte supernatant, interleukin 1 (IL-1), alpha-interferon (alpha IFN), or interleukin 2 (IL-2) greatly increased the magnitude of Cur killing and accelerated the kinetics of lysis. The addition of prostaglandin E2 (PGE2) during in vitro activation of NK by IL-2 profoundly inhibited subsequent Cur lysis, whereas only minimal inhibition of K562 lysis was noted. However, following activation with IL-2, lysis of Cur targets was less sensitive to the inhibitory effects of PGE2. Removal of Leu 11b(+), OKM1(+), or L-leucyl-leucine methyl ester-sensitive cells markedly decreased both Cur and K562 lysis. Moreover, CD16(+) cells purified with the fluorescence-activated cell sorter were found to mediate Cur killing. Whereas Cur and K562 lysis is mediated by phenotypically similar effector cells, the present studies demonstrate that the cytotoxic functions defined by the ability to lyse these two targets differ in response to a variety of immunoregulatory stimuli.
Kanar
M C
MC
Harold C. Simmons Arthritis Research Center, Department of Internal Medicine, University of Texas Health Science Center, Southwestern Medical School, Dallas 75235.
Thiele
D L
DL
Ostensen
M
M
Lipsky
P E
PE
D002460:Cell Line; D003602:Cytotoxicity, Immunologic; D015232:Dinoprostone; D006801:Humans; D066298:In Vitro Techniques; D007213:Indomethacin / Q000276:immunology; D007376:Interleukin-2 / Q000276:immunology; D007680:Kidney Neoplasms / Q000276:immunology; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D007700:Kinetics; D008222:Lymphokines / Q000276:immunology; D008264:Macrophages / Q000276:immunology*; D011458:Prostaglandins E / Q000276:immunology; D011459:Prostaglandins E, Synthetic / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*
D007376:Interleukin-2; D008222:Lymphokines; D011458:Prostaglandins E; D011459:Prostaglandins E, Synthetic; D015232:Dinoprostone; D007213:Indomethacin